Related Experiment Video
Updated: May 22, 2026

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
Published on: December 27, 2013
[The effect of botulinum A toxin repeated injection in treating blepharospasm and hemifacial spasm]
1Department of Otorhinolaryngology, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China. jinling-w@fmmu.edu.cn
Objective:
To study the long-term efficacy of botulinum A toxin (BTXA) repeated injection for the treatment of blepharospasm and hemifacial spasm (HFS).
Method:
Eighty patients with blepharospasm and/or HFS (75 sides and 65 sides respectively) were treated with constant BTXA local repeated injection over 4 times and the dosage was 12.5-15.0 U and 22.5-32.5 U respectively in each injection. A total number of 886 injections were given. All the patients were followed up for 2-8 years.
Result:
The earliest effect was found in 2-3 days after the treatment. The effective ratios of the partial relieved, remarkably relieved and completely relieved in blepharospasm and HFS were 0, 67.7%, 32.7% and 1.4%, 72.3%, 26.3% respectively. The average duration of improvement lasted about (19.9 +/- 4.5) weeks and (20.7 +/- 4.2) weeks respectively (P>0.05), which increased with the times of injection. The local side effects were mild and transient.
Conclusion:
BTXA for the treatment of blepharospasm and HFS is a safe, effective and simple method.
Related Concept Videos
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Skeletal Muscle Relaxants: Therapeutic Uses
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...

